Evidence status: each field states its source quality, applicability, and review date. Research pending, information not established, and vendor documentation pending remain distinct outcomes.
Product overview
Start with the essentials
Concurrent-reading software that highlights suspected fractures on labeled adult radiographs for physician review.
Overview status: Source-reviewed overview
What does this software do?It analyzes radiographs and highlights areas suspicious for fractures as a concurrent reading aid during physician interpretation.
Which images is it intended for?It accepts DICOM radiographs of labeled adult extremity, pelvic, rib, and spine regions, including the ankle, wrist, shoulder, hip, ribs, and thoracic or lumbosacral spine.
Who uses it?Radiologists, physicians, and trained radiology or orthopedic professionals use it in radiology and orthopedic imaging workflows.
What does the software produce?It returns result DICOM images and summary information with annotations or highlighted areas; the original images are not altered.
What is its most important limitation?The labeled use is limited to supported adult radiograph views. Results aid, but do not replace, full image review, clinical examination, or physician judgment.
Clinical takeaway
BoneView adds concurrent fracture highlights within its labeled adult radiograph scope; clinicians still perform the complete image review and clinical assessment.
Evidence takeaway
The FDA submission reports standalone fracture-detection results from 8,918 adult radiographs at two operating points. Those results are limited to the stated endpoint, population, operating point, and BoneView version; they are not reader-aided or site-performance claims.
Clinical details
What this tool is for
Start with the authorized purpose, then verify how it fits your service line and reading workflow.
Exact purpose
BoneView is a concurrent reading aid that analyzes radiographs and highlights areas suspicious for fractures in adults during physician interpretation.
The FDA labeling limits the supported adult radiograph views and requires physician interpretation. Results are an aid and do not replace full image review, clinical examination, or judgment.
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
Use these fields to structure a vendor demo, security review, and implementation estimate.
Integration
The FDA package describes DICOM source and destination through PACS or an X-ray system, with an intermediate DICOM node, gateway, or API for processing and result return.
Public materials reviewed for this exact submission do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
Training and support
Use by radiologists, physicians, and trained radiology or orthopedic professionals. Follow the exact labeling, local training, supervision, and escalation requirements.
The FDA package describes DICOM source and destination through PACS or an X-ray system, with an intermediate DICOM node, gateway, or API for processing and result return.
Monitor labeling, software version, complaints, recalls, failed inputs, overrides, and postmarket signals against the exact submission and installed configuration.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
K212365 FDA decision material reports the exact evidence metrics included below for BoneView; values are limited to the stated endpoint, population, and operating point.
Previous value withdrawn: The legacy value combines multiple unlabeled numbers and does not identify an endpoint, operating point, population, or tested version. Use the scoped exact-submission evidence metrics instead.
Reported specificity
Value withdrawn pending re-verification
Corrected record
Exact FDA submission
Checked 2026-09-14
Previous value withdrawn: The legacy value combines multiple unlabeled numbers and does not identify an endpoint, operating point, population, or tested version. Use the scoped exact-submission evidence metrics instead.
Standalone sensitivity at high-sensitivity operating point
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
No record matched K212365 by exact native submission identifier in the 2026-09-02 openFDA snapshot; this does not exclude product-family, later-version, or adverse-event information.
Verify security and privacy controls: Public materials reviewed for this exact submission do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
Verify pricing and total cost: No public list price or commercial contract for the exact submission and version was identified.
Verify reimbursement and coding relevance: No exact-product payer coverage or reimbursement determination was identified in reviewed public material.
This audit distinguishes completed source review from fields that have not yet been researched.
Human reviewedStatus
2026-09-04Last searched
27Fields reviewed
11Source classes checked
20Screened PubMed leads
6Screened trial leads
0Unreviewed FDA recall leads
No evidence was promoted. Several records name BoneView, but none identifies the tested build tied to K212365; NCT04532580 says FDA submission but omits the submission number and software version, and other records are pediatric, family-level, or unrelated. The current discovery snapshot contains 20 PubMed and 6 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall
Sources & history
How this profile was documented
Open the ledger for source dates, scope, and research-record updates.
View source ledger and history7 sources - 3 history items
Opportunistic review of frontal lumbar-spine or KUB radiographs in adults aged 50 years and older to flag possible low bone mineral density at L1-L4 for clinician follow-up; a...
Rayvolve supports clinicians by identifying suspected fractures, joint effusions, and dislocations on labeled radiographic views; it does not replace clinician interpretation.
Modality
X-ray/Radiography
Anatomy
Musculoskeletal and chest/ribs radiographs across specified views
Concurrent-read CADe to assist dentists in detecting specified tooth and jaw anatomy, bone-level landmarks, and root-canal-treated teeth in digital radiographs of permanent teeth...
Modality
X-ray/Radiography
Anatomy
Permanent teeth and jaw/maxillofacial anatomy, including enamel, dentine, pulp, root, mental foramen, inferior alveolar canal, maxillary sinus, cementoenamel junction, crestal bone, and root-canal-treated teeth
qXR-Detect is an adult chest-radiograph concurrent reading aid that identifies, highlights and categorizes suspicious regions of interest across lung, pleura,...
Modality
X-ray/Radiography
Anatomy
Chest/Lung; pleura, mediastinum/hila/heart, bone, hardware and other chest-radiograph regions